About Novartis Oncology Slovenia

Novartis Oncology is an integral part of Novartis Pharma Services, Inc. Representative office Slovenia. In close cooperation with Slovene doctors who treat patients with cancer (hematologists, oncologists, pulmonologists, gastroenterologists, surgeons) we take care of the best possible treatment of these patients, by encouraging the spread of knowledge about new medicines, about new ways of treatment and by working to make these medicines available to everybody in Slovenia who need them.

Novartis Oncology markets medicines used in treatment of patients with various cancerous diseases, mainly in the area of:

• Chronic myeloid leukemia - Glivec^® (imatinib), Tasigna^® (nilotinib)
• Iron overload - Exjade^® (deferasirox), Desferal^® (deferoxamine)
• Breast cancer - Femara^® (letrozole)
• Complications due to bone metastases at various cancers (breast, prostate, lung, multiple myeloma) - Zometa^® (zolendronic acid), Aredia^® (pamidronic acid)
• Neuroendocrine tumors, acromegaly - Sandostatin LAR^® (octreotide)
• Gastrointestinal stromal tumors (GIST) - Glivec^® (imatinib)

Contact Information

Novartis Pharma Services Inc.
Representative office Slovenia
Business unit Oncology
Tivolska cesta 30
1000 Ljubljana
Slovenia

Novartis Onkologija v Sloveniji je sestavni del slovenske podružnice Novartis Pharma Services, Inc. V tesnem sodelovanju s slovenskimi zdravniki, ki zdravijo onkološke bolnike (hematologi, onkologi, urologi, pulmologi, endokrinologi, gastroenterologi, kirurgi različnih strok) skrbimo za čimboljše zdravljenje teh bolnikov tako, da znanje o novih zdravilih, načinih zdravljenja in nova zdravila čimprej pridejo do vseh, ki jih v Sloveniji potrebujejo.

Novartis onkologija trži zdravila za zdravljenje bolnikov z različnimi rakavimi obolenji, predvsem na naslednjih področjih

• Kronična mieloična levkemija - Glivec® (imatinib), Tasigna® (nilotinib)
• Preobremenitev z železom - Exjade® (deferasiroks), Desferal® (deferoksamin)
• Rak dojke - Femara® (letrozol)
• Zapleti pri kostnih metastazah pri različnih vrstah rakov (dojka, prostata, pljuča, multipli mielom) - Zometa® (zolendronska kislina), Aredia® (pamidronska kislina)
• Nevroendokrini tumorji, akromegalija - Sandostatin LAR® (oktreotid)
• Gastrointestinalni stromalni tumorji (GIST) - Glivec® (imatinib)

Naslov:

Novartis Pharma Services Inc.
Podružnica v Sloveniji
Poslovna enota Onkologija
Tivolska cesta 30
1000 Ljubljana
Slovenija